Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature Review

Institutions

Publication Details

Journal
Advances in Therapy
Published
2026-03-24
DOI
https://doi.org/10.1007/s12325-026-03559-7
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature Review

Advances in Therapy
Diabetes Treatment and Management
article

Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature Review

article en

Abstract

No abstract available for this paper.
Advances in Therapy
AstraZeneca (United Kingdom) (GB), University of Copenhagen (DK), University of Padua (IT), University of Toronto (CA), Peking University (CN), University of California, Irvine Medical Center (US), Peking University People's Hospital (CN), Institut des Maladies Métaboliques et Cardiovasculaires (FR), Wythenshawe Hospital (GB), Institut Català de la Salut (ES), Costello Medical Consulting (United Kingdom) (GB), Toranomon Hospital (JP), Université de Rennes (FR), Martin Luther University Halle-Wittenberg (DE)
Good health and well-being
Openalex Percentile: Top 12%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature Review · Advances in Therapy (2026) | TGRS Research Map | TGRS